OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2024
OCUMENSION-B: 2023 Environmental, Social and Governance Report
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE II CLINICAL TRIAL OF OT-202
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024
OCUMENSION-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
OCUMENSION-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return (Resubmission)
OCUMENSION-B: Next Day Disclosure Return (Resubmission)
OCUMENSION-B: Next Day Disclosure Return
OCUMENSION-B: Next Day Disclosure Return
No Data